Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DYNAVAX TECHNOLOGIES CORP | Director | Common Stock | 17.6K | $200K | $11.39 | May 23, 2024 | Direct |
DYNAVAX TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 22.5K | May 23, 2024 | Direct | ||
Histogen Inc. | Director | Stock Option (right to buy) | 6.84K | Jun 20, 2023 | Direct | ||
Oncternal Therapeutics, Inc. | Director | Stock Options | 2.2K | Jun 20, 2024 | Direct | ||
Zynerba Pharmaceuticals, Inc. | Director | Common Stock | 0 | $1.33 | Oct 10, 2023 | Direct | |
Zynerba Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 10, 2023 | Direct |